Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular....
Work for Aciont? Take ownership of your company’s profile and submit the latest details about your company to keep the investors, strategics, and service providers using our database up-to-date on the work being done at your company.
